Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any microphthalmia, isolated, with coloboma in which the cause of the disease is a mutation in the ABCB6 gene.
Features include always present findings: Iris coloboma and Inferior chorioretinal coloboma; and sometimes findings: Microphthalmia.
ABCB6 encodes ATP binding cassette subfamily B member 6 (LAN blood group) (842 aa). ATP-dependent transporter that catalyzes the transport of a broad-spectrum of porphyrins from the cytoplasm to the extracellular space through the plasma membrane or into the vesicle lumen. Highest expression in Testis (101.0 TPM) and Ovary (98.5 TPM).
Microphthalmia, isolated, with coloboma 7 has limited evidence linking it to mutations in the ABCB6 gene on chromosome 2.
The ABCB6 protein participates in Defective ABCB6 causes MCOPCB7, ABCB6 transports porphyrin from cytosol to mitchondrial matrix, and Defective ABCB6 does not transport porphyrin from cytosol into mitochondria matrix pathways.
ABCB6 is classified as a druggable target (Abc Transporter, Druggable Genome, and Transporter categories) with score 0.0.
16 pathogenic variants reported in ABCB6 in ClinVar, including hotspot variants 1284646 and 68473.
Genetic testing for ABCB6 is available. Testing is considered research-grade for diagnosis.
Phenotype severity distribution: 2 always present features.
No clinical trials have been registered for microphthalmia, isolated, with coloboma 7.
5 publications have been identified in PubMed for microphthalmia, isolated, with coloboma 7. Research spans Review / Meta-Analysis (60%), Case Report / Case Series (20%), and Basic Science / Preclinical (20%).
Merepa SS (2025). [PMID: 40301690](https://pubmed.ncbi.nlm.nih.gov/40301690/). *European journal of human genetics : EJHG*. [Basic Science / Preclinical]
Russo M (2025). [PMID: 40038803](https://pubmed.ncbi.nlm.nih.gov/40038803/). *Italian journal of pediatrics*. [Review / Meta-Analysis]
Shiels A (2024). [PMID: 38927721](https://pubmed.ncbi.nlm.nih.gov/38927721/). *Genes*. [Review / Meta-Analysis]
Laasri K (2024). [PMID: 39280748](https://pubmed.ncbi.nlm.nih.gov/39280748/). *Radiology case reports*. [Case Report / Case Series]
Mahmoud A (2024). [PMID: 38350011](https://pubmed.ncbi.nlm.nih.gov/38350011/). *Ocular immunology and inflammation*. [Review / Meta-Analysis]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 11:22 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center